PRO-DRUGS OF DOPAMINERGIC AGONISTS

被引：0

作者：

HORN, AS

机构：

来源：

CHEMISTRY & INDUSTRY | 1980年 / 11期

关键词：

D O I：

暂无

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

引用

页码：441 / 443

页数：3

共 50 条

[21] ISOTHIAZOLONE BIOCIDES - ENZYME-INHIBITING PRO-DRUGS
COLLIER, PJ
AUSTIN, P
GILBERT, P
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 74 (2-3) : 195 - 201
[22] PREPARATION AND CHARACTERIZATION OF PRO-DRUGS OF THE PRAZIQUANTEL POTENTIALLY SCHISTOSOMICIDS
DENARVAEZ, AJR
ARAUJO, S
ACTA CIENTIFICA VENEZOLANA, 1988, 39 (5-6): : 451 - 455
[23] Cobalt (III) Complexes as Pro-drugs for Cancer Therapy
Zhang, Chen
Sutherland, Mathew
Chiang, Linus
Clarke, Ryan
Thompson, John
Walsby, Charles
Storr, Timothy
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[24] Synthesis and characterization of aminoacidic pro-drugs of valproic acid
Giannola, LI
Lamartina, L
de Caro, V
PHARMAZIE, 1998, 53 (12): : 829 - 834
[25] Synthesis of naproxen pro-drugs for enhanced transdermal absorption
Assali, Mohyeddin, 1600, Journal of Chemical and Pharmaceutical Research, 3/668 Malviya Nagar, Jaipur, Rajasthan, India (06):
[26] PRO-DRUGS AND 1ST-PASS EFFECTS
JOHNSON, P
CHEMISTRY & INDUSTRY, 1980, (11) : 443 - 447
[27] PRO-DRUGS FOR THE ORAL DELIVERY OF DISODIUM-CROMOGLYCATE
MORI, T
NISHIMURA, K
TAMAKI, S
NAKAMURA, S
TSUDA, H
KAKEYA, N
CHEMICAL & PHARMACEUTICAL BULLETIN, 1988, 36 (01) : 338 - 344
[28] WHAT ARE THE MECHANISMS BY WHICH PRO-DRUGS ARE ACTIVATED IN THE BODY
BUNDGAARD, H
JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1983, 8 (02): : 153 - 154
[29] ENHANCEMENT OF ORGANOLEPTIC AND STABILITY PROPERTIES OF ANTIBIOTICS BY USE OF PRO-DRUGS
SINKULA, AA
ACTA PHARMACEUTICA SUECICA, 1976, 13 : 7 - 8
[30] RENAL PRO-DRUGS OFFER NEW PERSPECTIVES IN IMMUNOSUPPRESSIVE THERAPY
RUERS, TJM
BUURMAN, WA
VANDERLINDEN, CJ
VANDONGEN, JJ
KOOTSTRA, G
TRANSPLANTATION PROCEEDINGS, 1986, 18 (04) : 907 - 909

← 1 2 3 4 5 →